Concomitant T790M mutation and small‐cell lung cancer transformation after acquired resistance to epidermal growth factor receptor‐tyrosine kinase inhibitor

類似資料

• Should Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Be Continued beyond Progressive Disease?
  著者:: Kim, Young Hak, 等
  出版事項: (2011)
• Predictors of Acquired T790M Mutation in Patients Failing First- or Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors
  著者:: Chai CS, 等
  出版事項: (2020-07-01)
• Predictors of Acquired T790M Mutation in Patients Failing First- or Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors
  著者:: Chai, Chee-Shee, 等
  出版事項: (2020)
• Resistance to epidermal growth factor receptor tyrosine kinase inhibitors, T790M, and clinical trials
  著者:: O’Kane, G.M., 等
  出版事項: (2018)
• A case of resistance to tyrosine kinase inhibitor therapy: small cell carcinoma transformation concomitant with plasma-genotyped T790M positivity
  著者:: Xu, Yanjun, 等
  出版事項: (2017)